A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin

Status:
Completed

Trial end date:
2016-08-01

Target enrollment:

Participant gender:

The purpose of this study is to determine whether PF-06291874 is effective in the treatment T2DM

Phase 2

Pfizer

Metformin